REPROGRAMACIÓN Y REGENERACIÓN NEURAL
Universidad del País Vasco/Euskal Herriko Unibertsitatea
Lejona, EspañaPublicaciones en colaboración con investigadores/as de Universidad del País Vasco/Euskal Herriko Unibertsitatea (10)
2022
-
Characterization of molecular biomarkers in cerebrospinal fluid and serum of E46K-SNCA mutation carriers
Parkinsonism and Related Disorders, Vol. 96, pp. 29-35
-
Mice in translational neuroscience: What R we doing?
Progress in Neurobiology
2021
-
Looking backward to move forward: a meta-analysis of stem cell therapy in amyotrophic lateral sclerosis
npj Regenerative Medicine, Vol. 6, Núm. 1
2018
-
iPS Cell Cultures from a Gerstmann-Sträussler-Scheinker Patient with the Y218N PRNP Mutation Recapitulate tau Pathology
Molecular Neurobiology, Vol. 55, Núm. 4, pp. 3033-3048
2016
-
Fast and efficient neural conversion of human hematopoietic cells
Current Protocols in Stem Cell Biology, Vol. 2016, pp. 1-20
-
Mutations in LRRK2 impair NF-ΚB pathway in iPSC-derived neurons
Journal of Neuroinflammation, Vol. 13, Núm. 1
2014
-
Buspirone anti-dyskinetic effect is correlated with temporal normalization of dysregulated striatal DRD1 signalling in l-DOPA-treated rats
Neuropharmacology, Vol. 79, pp. 726-737
-
Fast and efficient neural conversion of human hematopoietic cells
Stem Cell Reports, Vol. 3, Núm. 6, pp. 1118-1131
-
Leucine-rich repeat kinase 2 modulates cyclooxygenase 2 and the inflammatory response in idiopathic and genetic Parkinson's disease
Neurobiology of Aging, Vol. 35, Núm. 5, pp. 1116-1124
2012
-
The role of the subthalamic nucleus in L-DOPA induced dyskinesia in 6-hydroxydopamine lesioned rats
PLoS ONE, Vol. 7, Núm. 8